101 related articles for article (PubMed ID: 27083436)
1. A Sputum Proteomic Signature That Associates with Increased IL-1β Levels and Bacterial Exacerbations of COPD.
Damera G; Pham TH; Zhang J; Ward CK; Newbold P; Ranade K; Sethi S
Lung; 2016 Jun; 194(3):363-9. PubMed ID: 27083436
[TBL] [Abstract][Full Text] [Related]
2. Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients.
Tangedal S; Aanerud M; Persson LJ; Brokstad KA; Bakke PS; Eagan TM
Respir Res; 2014 Nov; 15(1):138. PubMed ID: 25398249
[TBL] [Abstract][Full Text] [Related]
3. Bacterial flora in the sputum and comorbidity in patients with acute exacerbations of COPD.
Boixeda R; Almagro P; Díez-Manglano J; Cabrera FJ; Recio J; Martin-Garrido I; Soriano JB
Int J Chron Obstruct Pulmon Dis; 2015; 10():2581-91. PubMed ID: 26664106
[TBL] [Abstract][Full Text] [Related]
4. Ex-vivo RNA expression analysis of vaccine candidate genes in COPD sputum samples.
Brettoni C; Muzzi A; Rondini S; Weynants V; Rossi Paccani S
Respir Res; 2023 Oct; 24(1):243. PubMed ID: 37798723
[TBL] [Abstract][Full Text] [Related]
5. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.
Wilkinson TMA; Hurst JR; Perera WR; Wilks M; Donaldson GC; Wedzicha JA
Chest; 2006 Feb; 129(2):317-324. PubMed ID: 16478847
[TBL] [Abstract][Full Text] [Related]
6. Responsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls.
Kawayama T; Kinoshita T; Matsunaga K; Kobayashi A; Hayamizu T; Johnson M; Hoshino T
Int J Chron Obstruct Pulmon Dis; 2016; 11():295-303. PubMed ID: 26929615
[TBL] [Abstract][Full Text] [Related]
7. IL-1α/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice.
Botelho FM; Bauer CM; Finch D; Nikota JK; Zavitz CC; Kelly A; Lambert KN; Piper S; Foster ML; Goldring JJ; Wedzicha JA; Bassett J; Bramson J; Iwakura Y; Sleeman M; Kolbeck R; Coyle AJ; Humbles AA; Stämpfli MR
PLoS One; 2011; 6(12):e28457. PubMed ID: 22163019
[TBL] [Abstract][Full Text] [Related]
8. Expression of Siglec-9 in peripheral blood neutrophils was increased and associated with disease severity in patients with AECOPD.
Ge L; Wang N; Chen Z; Xu S; Zhou L
Cytokine; 2024 May; 177():156558. PubMed ID: 38412768
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the expression of the NF-κB family member RelB as a novel marker of cardiovascular outcomes during acute exacerbations of chronic obstructive pulmonary disease.
Labonté L; Coulombe P; Zago M; Bourbeau J; Baglole CJ
PLoS One; 2014; 9(11):e112965. PubMed ID: 25409035
[TBL] [Abstract][Full Text] [Related]
10. Research Progress of Inflammatory Factors in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension at High Altitude.
Huang H; Yang L
Altern Ther Health Med; 2023 Nov; 29(8):689-693. PubMed ID: 37678877
[TBL] [Abstract][Full Text] [Related]
11. The Most Common Detected Bacteria in Sputum of Patients with the Acute Exacerbation of COPD.
Cukic V
Mater Sociomed; 2013 Dec; 25(4):226-9. PubMed ID: 24511262
[TBL] [Abstract][Full Text] [Related]
12. A Refined View of Airway Microbiome in Chronic Obstructive Pulmonary Disease at Species and Strain-Levels.
Wang Z; Liu H; Wang F; Yang Y; Wang X; Chen B; Stampfli MR; Zhou H; Shu W; Brightling CE; Liang Z; Chen R
Front Microbiol; 2020; 11():1758. PubMed ID: 32849386
[TBL] [Abstract][Full Text] [Related]
13. Cytokine patterns in critically ill patients undergoing percutaneous tracheostomy.
Trahtemberg U; Bazak N; Sviri S; Beil M; Paschke S; van Heerden PV
Clin Exp Immunol; 2019 Oct; 198(1):121-129. PubMed ID: 31125429
[TBL] [Abstract][Full Text] [Related]
14. Prognostic assessment in COPD without lung function: the B-AE-D indices.
Boeck L; Soriano JB; Brusse-Keizer M; Blasi F; Kostikas K; Boersma W; Milenkovic B; Louis R; Lacoma A; Djamin R; Aerts J; Torres A; Rohde G; Welte T; Martinez-Camblor P; Rakic J; Scherr A; Koller M; van der Palen J; Marin JM; Alfageme I; Almagro P; Casanova C; Esteban C; Soler-Cataluña JJ; de-Torres JP; Miravitlles M; Celli BR; Tamm M; Stolz D
Eur Respir J; 2016 Jun; 47(6):1635-44. PubMed ID: 27103389
[TBL] [Abstract][Full Text] [Related]
15. COPD immunopathology.
Caramori G; Casolari P; Barczyk A; Durham AL; Di Stefano A; Adcock I
Semin Immunopathol; 2016 Jul; 38(4):497-515. PubMed ID: 27178410
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab treatment in asthma-COPD overlap syndrome.
Tat TS; Cilli A
J Asthma; 2016 Dec; 53(10):1048-50. PubMed ID: 27144514
[TBL] [Abstract][Full Text] [Related]
17. Comparison of serum biomarkers between patients with asthma and with chronic obstructive pulmonary disease.
Han SS; Lee WH; Hong Y; Kim WJ; Yang J; Lim MN; Lee SJ; Kwon JW
J Asthma; 2016 Aug; 53(6):583-8. PubMed ID: 27104648
[TBL] [Abstract][Full Text] [Related]
18. COPD Readmissions: Addressing COPD in the Era of Value-based Health Care.
Shah T; Press VG; Huisingh-Scheetz M; White SR
Chest; 2016 Oct; 150(4):916-926. PubMed ID: 27167208
[TBL] [Abstract][Full Text] [Related]
19. Frequent Exacerbator: The Phenotype at Risk of Depressive Symptoms in Geriatric COPD Patients.
Tse HN; Tseng CZ; Wong KY; Ng LY; Lai TL; Yee KS
Lung; 2016 Aug; 194(4):665-73. PubMed ID: 27140193
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
Donohue JF; Wise R; Busse WW; Garfinkel S; Zubek VB; Ghafouri M; Manuel RC; Schlenker-Herceg R; Bleecker ER
BMC Pulm Med; 2016 Apr; 16(1):65. PubMed ID: 27130202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
